Search results

Order by most recent / most popular / relevance

Results: 1-10 of 853

Competition Authority publishes long-awaited report into pharmaceuticals sector

Mehmet Gün & Partners
-
Turkey
-
May 15 2013

The Competition Authority recently concluded its investigation into the pharmaceutical sector, which commenced on January 20 2009. The authority

Healthcare concentrations: ACM keeps finger on pulse?

De Brauw Blackstone Westbroek
-
Netherlands
-
May 9 2013

The healthcare sector is likely to stay on the radar of the Authority for Consumers and Markets (ACM

Market enquiry provision to be used to investigate healthcare sector

DLA Cliffe Dekker Hofmeyr
-
South Africa
-
May 9 2013

Economic Development Minister Ebrahim Patel announced on Tuesday that the Competition Commission would investigate the private healthcare sector on

Teva Canada Innovation v. Attorney General of Canada

Borden Ladner Gervais LLP
-
Canada
-
May 8 2013

The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an

Federal Court sets aside PMPRB decision regarding COPAXONE syringes for the second time

Smart & Biggar/Fetherstonhaugh
-
Canada
-
May 7 2013

On April 30, 2013, Justice Zinn of the Federal Court set aside a decision of the PMPRB (the "Board"), which ordered (Order, Reasons) Teva to pay the

The FTC weighs in on recent state efforts to promotehinder healthcare competition from APRNs

Baker & Hostetler LLP
-
USA
-
May 2 2013

In recent years, the Federal Trade Commission (FTC) frequently has commented on state efforts to either expand or restrict competition faced by

UK Office of Fair Trading moves on pharma pay for delay

McGuireWoods LLP
-
United Kingdom
-
May 1 2013

On 19 April 2013, the UK Office of Fair Trading (OFT) announced that it had issued a Statement of Objections (preliminary statement of case) to a

Promoting healthcare competition the FTC’s recent comments on state legislativeregulatory efforts impacting competition from APRNs

Baker & Hostetler LLP
-
USA
-
April 30 2013

In recent years, the Federal Trade Commission ("FTC") has frequently commented on state efforts to either expand, or restrict competition faced by

FTC's new Chairwoman Ramirez says health care continues to be top priority

McDermott Will & Emery
-
USA
-
April 26 2013

In remarks made this week at the International Competition Network annual conference, Federal Trade Commission (FTC) Chairwoman Edith Ramirez stated

Health care concentrations: ACM keeps finger on pulse?

De Brauw Blackstone Westbroek
-
Netherlands
-
April 25 2013

The health care sector is likely to stay on the ACM's radar. Not only has the application of the separate notification thresholds for concentrations

next >

Search results

Competition Authority publishes long-awaited report into pharmaceuticals sector

Healthcare concentrations: ACM keeps finger on pulse?

Market enquiry provision to be used to investigate healthcare sector

Teva Canada Innovation v. Attorney General of Canada

Federal Court sets aside PMPRB decision regarding COPAXONE syringes for the second time

The FTC weighs in on recent state efforts to promotehinder healthcare competition from APRNs

UK Office of Fair Trading moves on pharma pay for delay

Promoting healthcare competition the FTC’s recent comments on state legislativeregulatory efforts impacting competition from APRNs

FTC's new Chairwoman Ramirez says health care continues to be top priority

Health care concentrations: ACM keeps finger on pulse?

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea